The Growing Demand for ERCP: Key Trends and Market Insights

The global Endoscopic Retrograde Cholangiopancreatography (ERCP) market is witnessing substantial growth due to the increasing prevalence of pancreatic and biliary disorders. In 2024, the market was valued at USD 1.72 billion , and it is projected to reach USD 3.41 billion by 2032 , growing at a CAGR of 8.92% during the forecast period. ERCP is a vital minimally invasive procedure that helps in diagnosing and treating conditions affecting the bile and pancreatic ducts . It is commonly used for managing gallstones, bile duct strictures, pancreatic cancer, and other related disorders . With the rising incidence of these conditions, the demand for advanced diagnostic and therapeutic solutions continues to surge. Technological Advancements Fuel Market Growth One of the key drivers of the ERCP market is technological innovation . The introduction of AI-powered endoscopic imaging, improved duodenoscopes, advanced guidewires, and precision sphincterotomes has significantly enhanced th...